Rapport Therapeutics Stock
Rapport Therapeutics is a biotechnology company focused on developing precision medicines for neurological disorders. It utilizes receptor-associated proteins to identify small molecule drugs that modulate neurotransmitter receptors, aiming for greater efficacy and reduced side effects.
Founded: 2022
For more Rapport Therapeutics stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Abraham Ceesay Chief Executive Officer |
| Troy Ignelzi Chief Financial Officer |
| Swamy Yeleswaram, Ph.D. Chief Development Officer |
| Karina Chmielewski Chief Information Officer & Head of Operations |
| Kathy Wilkinson Chief People Officer |
| David Bredt, Ph.D. Co-Founder & Chief Scientific Officer |
| Steven Paul, MD Co-Founder & Chairman |
| Brad Galer, MD Chief Medical Officer |
| Cheryl Gault Chief Operating Officer |
